Recently, Beijing Shunjing Biomedical Technology Co., Ltd., Beijing Zhaoyan Biotechnology Co., Ltd. and Beijing Zhaoyan New Drug Research Center Co., Ltd. jointly announced that the three parties have formally signed a strategic cooperation agreement. The purpose of this cooperation is to integrate the superior resources of all parties, carry out in-depth cooperation in the fields of innovative drug development and evaluation, resource sharing, information exchange, etc., and jointly establish a full-chain R&D service system from early detection to commercial production.

Recently, Beijing Shunjing Biomedical Technology Co., Ltd., Beijing Zhaoyan Biotechnology Co., Ltd. and Beijing Zhaoyan New Drug Research Center Co., Ltd. jointly announced that the three parties have formally signed a strategic cooperation agreement. The purpose of this cooperation is to integrate the superior resources of all parties, carry out in-depth cooperation in the fields of innovative drug development and evaluation, resource sharing, information exchange, etc., and jointly establish a full-chain R&D service system from early detection to commercial production.